Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 31, Issue 4, Pages 538-545
Publisher
Informa UK Limited
Online
2015-05-28
DOI
10.3109/14756366.2015.1046062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New therapeutic options for advanced non-resectable malignant melanoma
- (2015) Simone Stadler et al. Advances in Medical Sciences
- Proton channels and exchangers in cancer
- (2015) Enrico Pierluigi Spugnini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma
- (2015) Tommaso Azzarito et al. CANCER LETTERS
- BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
- (2015) Francesco Spagnolo et al. OncoTargets and Therapy
- Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII
- (2014) Aiga Grandane et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII
- (2014) Aiga Grandane et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
- (2014) Stefano Fais et al. CANCER AND METASTASIS REVIEWS
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors
- (2014) Enrico P Spugnini et al. Journal of Translational Medicine
- Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity
- (2013) João Costa-Rodrigues et al. FEBS Journal
- Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed
- (2013) Stefano Ferrari et al. Journal of Translational Medicine
- Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
- (2013) Jai Moo Shin et al. Journal of Neurogastroenterology and Motility
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
- (2012) A. Calcinotto et al. CANCER RESEARCH
- Drug Resistance: Challenges to Effective Therapy
- (2012) M. P.V. Shekhar CURRENT CANCER DRUG TARGETS
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
- (2012) Roel H. Wilting et al. DRUG RESISTANCE UPDATES
- Discovering gene–environment interactions in Glioblastoma through a comprehensive data integration bioinformatics method
- (2012) Brian Kunkle et al. NEUROTOXICOLOGY
- The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
- (2012) Matteo Bellone et al. OncoImmunology
- Clinical and pharmacokinetic evaluation of satraplatin
- (2011) Gury Doshi et al. Expert Opinion on Drug Metabolism & Toxicology
- Fotemustine for the treatment of melanoma
- (2011) Gaëlle Quéreux et al. EXPERT OPINION ON PHARMACOTHERAPY
- Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors
- (2011) Enrico P Spugnini et al. Journal of Translational Medicine
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy
- (2010) Enrico P Spugnini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
- (2009) Angelo De Milito et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review
- (2009) Fu-Shing Liu Taiwanese Journal of Obstetrics & Gynecology
- Proton pump inhibitors: an update of their clinical use and pharmacokinetics
- (2008) Shaojun Shi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Mathematical modelling of tumour acidity
- (2008) Kieran Smallbone et al. JOURNAL OF THEORETICAL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now